PTK2 and ovarian cancer: In addition, the fact that both OPG and malignant ascites activate integrin/FAK signaling and attenuate TRAIL-induced apoptosis suggest that integrin signaling is central to protect ovarian cancer cells from TRAIL cytotoxicity.